Procter & Gamble ads for Align probiotic supplement meet the National Advertising Division's high standards for making "doctor recommended" claims, the Council of Better Business Bureaus division says in a Sept. 14 release. NAD says it "closely scrutinizes these types of claims and requires highly reliable supporting evidence as substantiation" because doctor recommended claims "carry a great deal of weight with consumers." NAD found an independent survey by Wolters Kluwer adequately supports the claim "Align is the #1 gastroenterologist-recommended probiotic supplement that helps you build and maintain a stronger, healthier digestive system." The watchdog group notes P&G does not and should not say doctors recommend the product for specific symptoms. NAD also questioned claims that Align is "clinically proven" to protect against five signs of digestive imbalance. P&G volunteered to discontinue the claims - a move NAD says is "necessary and proper.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.
President Trump's ongoing interest in the policy, which would ensure the US government pays no more for prescription drugs than the lowest price available in comparable countries, continues to gain attention.
HHS Secretary Robert F. Kennedy Jr. regularly decries the “conflicts of interest” he believes abound in advisory committees, but his concerns, as well as a recent “policy directive” eliminating industry representatives, seem driven by a misunderstanding of the panels’ jobs.
